HP and Limb Kind Foundation Expand Access to Prosthetics with 3D Printing
The Limb Kind Foundation has joined forces with HP to advance the accessibility and customization of prosthetic devices through cutting-edge 3D printing technology. Their recent efforts highlight how digital workflows can significantly improve production efficiency and global reach.
Innovative Collaboration
Historically, the Limb Kind Foundation has relied on specialized teams traveling to underserved areas to craft prosthetics using traditional methods. The new partnership with HP introduces a digital-first approach that integrates scanning, design, and printing into a streamlined process using Multi Jet Fusion technology.
Pilot Program in Kenya
As part of a pilot project in Kenya, HP and the Foundation successfully produced five customized prosthetic sockets. The digital process began with 3D limb scans captured via smartphone, which were then shared with experts at Macy O&P. There, specialists created detailed digital molds using CAD software before forwarding the designs to Boston-based ABCorp, a manufacturing partner within HP’s global network. The final prosthetics were printed and post-processed with precision.
Recognition at Formnext Awards
The Limb Kind Foundation was nominated as a finalist in the Design Category at this year’s Formnext Awards, an event that honors exceptional contributions to 3D printing across fields such as education, startups, sustainability, and innovative design.
"The collaboration between HP and the Limb Kind Foundation demonstrates how technology can redefine the reach and quality of custom prosthetics for children worldwide."
About the Initiative
The initiative showcases how digital workflows and HP’s advanced 3D printing technologies can democratize access to personalized prosthetics, particularly for children in low-resource environments.
Author’s summary: HP and the Limb Kind Foundation use digital 3D printing workflows to make affordable, custom prosthetics accessible to children globally, starting with a successful trial in Kenya.